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Neisseria gonorrhoeae PilC1 is a member of the PilC family of type IV pilus-associated adhesins found in Neisseria species and
other type IV pilus-producing genera. Previously, a calcium-binding domain was described in the C-terminal domains of PilY1
of Pseudomonas aeruginosa and in PilC1 and PilC2 of Kingella kingae. Genetic analysis of N. gonorrhoeae revealed a similar
calcium-binding motif in PilC1. To evaluate the potential significance of this calcium-binding region in N. gonorrhoeae, we pro-
duced recombinant full-length PilC1 and a PilC1 C-terminal domain fragment. We show that, while alterations of the calcium-
binding motif disrupted the ability of PilC1 to bind calcium, they did not grossly affect the secondary structure of the protein.
Furthermore, we demonstrate that both full-length wild-type PilC1 and full-length calcium-binding-deficient PilC1 inhibited
gonococcal adherence to cultured human cervical epithelial cells, unlike the truncated PilC1 C-terminal domain. Similar to
PilC1 in K. kingae, but in contrast to the calcium-binding mutant of P. aeruginosa PilY1, an equivalent mutation in N. gonor-
rhoeae PilC1 produced normal amounts of pili. However, the N. gonorrhoeae PilC1 calcium-binding mutant still had partial
defects in gonococcal adhesion to ME180 cells and genetic transformation, which are both essential virulence factors in this hu-
man pathogen. Thus, we conclude that calcium binding to PilC1 plays a critical role in pilus function in N. gonorrhoeae.
Neisseria gonorrhoeae, a Gram-negative diplococcus, is thecausative agent of the sexually transmitted disease gonorrhea.
According to the CDC, there were more than 300,000 U.S. cases of
gonorrhea reported in 2011 (1); however, estimates are that the
number of infections is more likely to be around 870,000 per year
(2). Reports of gonococcal antibiotic resistance have led the Cen-
ters for Disease Control and Prevention to drop their recommen-
dation of cefixime as a first-line regimen in favor of more compli-
cated combination therapies (3). This makes it increasingly clear
that development of novel antimicrobial drugs is a necessity and
will require a fundamental understanding of all facets of N. gon-
orrhoeae infection.
It has been a challenge to develop an effective vaccine targeting
N. gonorrhoeae because of its highly variable surface components.
In addition, this pathogen manipulates the host’s immune de-
fenses by evading the adaptive immune response and recruiting
neutrophils to serve as a protective niche for further colonization
(4–7). One mechanism that N. gonorrhoeae uses during early col-
onization is adherence to human cervical epithelial cells prior to
the formation of microcolonies on the cell surface (8). Adhesion
to epithelial cells appears to be mediated by a tip-associated type
IV pilus (T4P) adhesin, PilC, which is also necessary for pilus
extension (9). After initial interaction with the cell, the gonococcal
pilus undergoes retraction by the action of the ATPase PilT, which
positions the bacterium near the cell surface, allowing subsequent
interactions necessary for colonization to occur (8).
The 110-kDa N. gonorrhoeae PilC protein was first identified as
a high-molecular-weight contaminant in highly purified pilus
preparations (10). All pathogenic Neisseria genomes completed to
date contain two similar pilC genes, pilC1 and pilC2, with the
greatest homology being in the C-terminal (CT) domains (11).
PilC1 purified from N. gonorrhoeae competitively blocks bacterial
adherence to human epithelial cells, lending credence to its im-
portant role in mediating adherence (12–14). In Neisseria menin-
gitidis, the N-terminal region of PilC1 is responsible for the inter-
action between the bacteria and the host cell receptor (11). It has
been reported that the initial adherence of N. gonorrhoeae to hu-
man cells is facilitated by the human complement cell receptor
CD46 (15, 16); however, there is conflicting evidence that attach-
ment is CD46 independent (12, 17). Preliminary evidence also
suggests that CD147 may be the cellular receptor for the menin-
gococcal pilus (18).
The reason for the redundancy of the PilC proteins in the
gonococcal genome is unclear, and it remains to be determined
whether PilC1 and PilC2 proteins play separate roles during infec-
tion. For the purpose of these studies, we will refer to NGO0055 as
pilC1 and NGO1912 as pilC2 because they are not identified as
pilC1 and pilC2 in the FA1090 genome. This name assignment was
based on the shared synteny of the loci when the completed Neis-
seria genomes are compared. Both pilC1 and pilC2 genes can un-
dergo phase variation by slipped-strand mispairing of the ho-
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mopolymeric “G” tract in the sequence encoding the signal
peptide, controlling the expression of the corresponding PilC pro-
tein (10, 19). This further complicates the study of PilC proteins
but may provide a mechanism for selective expression of either
PilC1 or PilC2 or both during pathogenesis. Because phase varia-
tion of PilC would profoundly affect the phenotypes associated
with T4P, we have taken steps in this study to prevent phase vari-
ation of both PilC genes.
Type IV pili (T4P) are found in a broad range of Gram-nega-
tive bacterial species (see Tables S1 and S2 in the supplemental
material) but are best studied in the Neisseria, Pseudomonas, and
Myxococcus genera (20). N. gonorrhoeae T4P are polymeric struc-
tures predominately composed of an 18-kDa pilin protein, PilE
(21). In addition to their role during adhesion to host cells, T4P
are essential for several other bacterial functions, including DNA
uptake (19, 20, 22). Pilin can evade immune recognition by un-
dergoing antigenic variation, a process during which silent pilS
loci undergo nonreciprocal homologous DNA exchange with the
pilE locus (6, 23, 24). Antigenic variation of the pilus was per-
ceived to be a complicating factor in our studies of the effects of
calcium-binding defects on T4P-related phenotypes. We have
therefore taken steps to ensure that all of the gonococcal strains
used in this work have the same pilE sequence.
The function and biogenesis of the P. aeruginosa type IV pili are
dependent on PilY1 (Pseudomonas aeruginosa PilC ortholog)
binding calcium, leading researchers to hypothesize that calcium-
bound and -unbound forms correspond to pilus extension and
retraction, respectively (25). We have identified a similar calcium-
binding domain in the C-terminal region of PilC1 and examined
its role in N. gonorrhoeae. We describe a new expression and pu-
rification method for PilC1 that increased yield. Furthermore, we
show that a gonococcal mutant with the D708A change in the
pilC1 gene [pilC1(D708A)] expressed a similar amount of pili on
the surface to a bacterial strain expressing wild-type (wt) PilC1.
Additionally, despite normal expression of pili on the surface, the
gonococcal strain expressing the D708A mutation in PilC1 had a
significantly reduced ability to adhere to ME180 cells and a partial
defect in the ability to undergo DNA transformation. Thus, we
conclude that these key pilus functions require PilC to be able to
bind calcium.
MATERIALS AND METHODS
Protein constructs, expression, and purification. Standard ligation-in-
dependent cloning techniques, as described by Stols et al. (26), were used
to construct the expression plasmids encoding the segments of PilC1. The
pilC1 gene encodes a 33-amino-acid signal peptide, which was omitted
from all of our expression constructs. All residue numbers are based on
the reading frame, excluding the signal peptide. Amplified DNA frag-
ments encoding full-length (FL) PilC1 (residues 1 to 1014) and the C-ter-
minal (CT) region of PilC1 (residues 496 to 1014) were treated and cloned
into an empty pMCSG7-Lic-His expression vector. All expression plas-
mids were verified by sequence analysis.
Expression plasmids were transformed into Escherichia coli BL21(DE3)
Origami 2 cells (Stratagene). Bacteria were grown in LB medium supple-
mented with ampicillin, streptomycin, and tetracycline at 37°C with shaking.
After the optical density at 600 nm (OD600) reached 0.6, IPTG (isopropyl--
D-thiogalactopyranoside) was added to a final concentration of 0.2 mM, and
bacteria were grown for another 12 h at 16°C with shaking. At the end of the
expression period, the bacteria were harvested, pelleted, and stored at 80°C.
Pelleted bacteria were thawed on ice and resuspended in lysis buffer (50 mM
sodium phosphate [pH 7.6], 500 mM sodium chloride, 25 mM imidazole)
supplemented with 0.5 mM EDTA, 0.1% Triton X-100, 1 mM phenylmeth-
ylsulfonyl fluoride (PMSF), one tablet of a protease inhibitor cocktail
(Roche), and 1 g/ml lysozyme. After 1 h of gentle stirring on ice, cells were
sonicated on ice for 1 min, and the lysate was centrifuged at 45,000  g for 90
min at 4°C. By using an ÄKTAxpress fast protein liquid chromatography
(FPLC) system (GE HealthCare), protein from the filtered soluble fraction
was purified by Ni-nitrilotriacetic acid (NTA) affinity column chromatogra-
phy. Recombinant His-PilC1 was eluted with buffer containing 50 mM so-
dium phosphate (pH 7.6), 500 mM sodium chloride, and 500 mM imidazole
and further purified by filtration through a Superdex 200 gel column (GE
Healthcare) equilibrated with 20 mM Tris-hydrochloride (pH 7.5), 250 mM
sodium chloride, 2 mM dithiothreitol, and 5% glycerol. Protein-containing
fractions were pooled, concentrated, flash-frozen in liquid nitrogen, and
stored at 80°C. The purified protein had a final purity of at least 95%, as
determined by SDS-PAGE.
Calcium-binding assay. Terbium ions were used as a substitute for
calcium because of their similar ionic radius and coordination properties.
Förster fluorescent resonance energy transfer (FRET) was carried out at
25°C using a SPEX Fluorolog-3 Research T-format spectrofluorometer
(Horiba Jobin Yvon, Edison, NJ). The protein sample was excited at 283
nm, and the terbium fluorescence emission was recorded at 543 nm. The
assay buffer contained 20 mM Tris-hydrochloride (pH 7.5) and 250 mM
sodium chloride. Terbium chloride was added in 0.2-l increments to
cuvettes containing 400 l of protein at a concentration of 0.2 mg/ml. The
error bars represent the standard deviation of three replicates. The data
were fitted to a one-site binding model.
CD spectroscopy. Far-UV circular dichroism (CD) spectra of wild-
type C-terminal PilC1 and D708A, D710A, and D716A mutants were
acquired by using a Chirascan spectropolarimeter (Applied Photophys-
ics). CD spectra were obtained from 260 nm to 205 nm using a 1-mm-
path-length cell at 22°C. The assay buffer contained 25 mM HEPES (pH
7.5) and 150 mM NaF. Thermal denaturation was analyzed by monitoring
ellipticity changes at 216 nm, while the sample was heated from 10 to 80°C
at a constant rate of 1°C every 2 min.
Cell lines. The human cervical epidermal cell line ME180 was grown
in McCoy’s 5A medium supplemented with 10% fetal bovine serum (FBS)
at 37°C in 5% CO2. The cells were grown to approximately 90% conflu-
ence in 96-well cell culture plates (Corning) prior to use in the cell adher-
ence assay.
Bacteria. All N. gonorrhoeae strains were grown overnight for 18 h on
Difco GC medium base (GCB)-agar plates (BD) containing Kellogg’s sup-
plement I (27) at 37°C in a humidified 5% CO2 atmosphere unless other-
wise stated. The strains used in this study are described in Table 1. The
strain intermediates, plasmids, and primers used to create these strains are
described in Tables S3 to S5 in the supplemental material. In general, the
changes in the pilE, pilC1, and pilC2 loci were introduced sequentially by





MS11 MKC wt (off) wt (on) wt (on)
FA1090 A23 wt (on) wt (off) pilE* (on)
FA7474 pilC1 pilC2 pilE
FA7461 pilC1 (PL on) pilC2 pilE
FA7480 pilC1 (PL on) pilC2 pilE* (on)
FA7489 pilC1 D708A (PL on) pilC2 wt (on)
FA7490 pilC1 D710A (PL on) pilC2 wt (on)
FA7491 pilC1 D716A (PL on) pilC2 wt (on)
FA7534 pilC1 D708A (PL on) pilC2 pilE* (on)
a pilC1 and pilC2 deletions remove the entire mature coding sequence.
b “PL on” refers to silent alteration of the third base in each codon of the poly(G) tract,
preventing phase shifting and locking the expression state in the “on” phase without
altering the expressed protein (13).
c pilE* encodes the native PilE found in FA1090 A23.
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using a modification of the method of Johnson and Cannon (28), always
maintaining expression of pilE and one intact pilC gene until the final step.
In strains such as FA7474 (pilE pilC1 pilC2) in which deletion of
either pilE or the expressed pilC would yield a transformation-incompe-
tent strain, the final strain was obtained by transformation with two
cloned DNAs simultaneously to introduce both of the desired mutations.
The changes introduced fell into two categories: deletions and alterations
of expressed genes. The deletions of pilC1 and pilC2 removed the entire
mature coding sequence, and the deletion in pilE removed 260 bp of
unique conserved pilE sequence, including its promoter and 105 bp en-
coding its N terminus. The alterations introduced served three purposes:
(i) the incorporation of silent changes to lock the expression phase of pilC
and create novel restriction sites used in subsequent subcloning efforts,
(ii) the alteration of the pilC1 coding sequence to create the proposed
calcium-binding mutants, and (iii) the restoration of a common PilE-
coding sequence to make the strains more biologically comparable. Each
of these alterations was introduced by a variation of the selectable/coun-
terselectable marker system used previously (28). All of the silent changes
were created with PCR primers containing the desired changes. The
changes altering the coding sequence of the proposed calcium-binding
domain were made by using the QuikChange II XL site-directed mutagen-
esis kit (Agilent Technologies).
As the final stage of selection, FA7474, FA7480, and FA7534 were
screened for Opa-nonexpressing isolates by performing whole-cell im-
munoblotting assays (29–32). Prior to these isolates’ use in any of the
biological experiments, each was sequenced to confirm the accuracy of
their pilE and pilC1 genes.
Cell adherence assay. Cell adherence assays were performed as previ-
ously described (12) by using the human epithelial ME180 cell line. In
gonococcal adherence inhibition experiments, ME180 cells were preincu-
bated with different concentrations of various recombinant proteins, fol-
lowed by a 1-h incubation period with a multiplicity of infection (MOI) of
100 for each gonococcal strain at 37°C and 5% CO2. The actual number of
bacteria placed on the cells was determined by spreading serial dilutions
of each strain on GCB agar plates. After 1 h, ME180 cells were washed
three times with Hanks’ balanced salt solution (HBSS) to remove the
nonadherent bacteria and exposed to 1% saponin in GCB for 10 min. This
lysate was pipetted vigorously and immediately diluted in GCB broth.
CFU were quantified by spreading serial dilutions of bacteria on GCB agar
plates. The percentage of gonococcal adherence was determined by divid-
ing the number of bacterial remaining bound by the number of bacteria
initially placed on the cells. In assays measuring the inhibition of gono-
coccal binding by recombinant protein, the percentage of bound bacteria
at each concentration of each protein was compared to that of a replicate
lacking any inhibitor. The percentage of inhibition was calculated by di-
viding the reduction in percentage of bacteria bound in the presence of
inhibitor by the percentage of bacteria bound by the uninhibited replicate.
Transformation frequency. Using a method adapted from Biswas et
al. (33), we grew gonococcal strains FA7474 (pilC1 pilC2 pilE),
FA7480 (PilC1), and FA7534 [PilC1(D708A)] overnight on GCB agar
plates. Bacteria were resuspended in GCB broth supplemented with 5 mM
MgCl2 and supplement I (glucose). These suspensions were balanced by
OD600, and approximately 10
8 CFU in 100 l was placed in each well of a
96-well microtiter plate (Falcon) with the indicated amount of plasmid
pUNCH977 (either 100 ng/ml or 4 g/ml). The plasmid pUNCH977
contains a rifampin-resistant allele of gonococcal rpoB(D543Y). The plate
was incubated for 30 min at 37°C with 5% CO2, followed by the addition
of 1/10 volume of DNase I (Sigma). Approximately 4 or 40 Kunitz units of
DNase I was used for those bacteria receiving 100 ng/ml and 4 g/ml
DNA, respectively. This represented more than a 100-fold excess when the
incubation was continued for 10 min at 37°C. Thereafter, 10 l of each
mixture was diluted in 90 l GC broth with supplement I, and the incu-
bation continued for 4.5 h. Each strain was serially diluted and plated in
triplicate on GCB plates and GCB plates supplemented with 5 g/ml
rifampin. The frequency of transformants was calculated by dividing the
number of rifampin-resistant CFU by the total CFU obtained on GCB
plates. The relative frequency was calculated in each experiment by divid-
ing the frequency of transformants of each strain by the frequency of
transformants of the positive-control strain (FA7480) so as to normalize
all experiments for comparison.
Flow cytometry. The two monoclonal antibodies used to detect sur-
face-exposed epitopes of PilC1 were derived from a BALB/c/J mouse im-
munized with denatured rPilC1. Monoclonal 4B5 recognized the con-
served C-terminal, linear epitope WRExFx, as judged by enzyme-linked
immunosorbent assay (ELISA) recognition of an alanine-substituted pep-
tide family (data not shown). This epitope is conserved in most gonococ-
cal and meningococcal PilC proteins. In contrast, the monoclonal anti-
body 1D5 recognized an N-terminal linear epitope found only in FA1090
PilC1 and only when presented in the context of an assembled pilus. The
epitope of 1D5 was YAIImDExn, as determined by ELISA recognition of
an alanine-substituted peptide family. (The lowercase letters indicate po-
sitions that caused a 30% reduction in peptide recognition when alanine
was substituted [data not shown].) All gonococcal strains were grown
overnight prior to being resuspended in GCB broth at the same optical
density at 600 nm. Approximately 1  109 CFU were incubated in 100 l
of primary antibody (used at a dilution of 1:100) in a U-bottom 96-well
plate (Corning) for 30 min at room temperature (RT). All samples were
washed 3 times by centrifugation at 500  g with GCB broth. Each sample
was then incubated with a 1:1,000 dilution of biotin-labeled anti-mouse
IgG (Jackson ImmunoResearch) for 30 min at RT prior to washing. Fi-
nally, streptavidin-phycoerythrin (PE) (Sigma) was used at a 1:1,000 di-
lution for an incubation period of 30 min at RT in the dark. After the final
wash step, each sample was resuspended in GCB broth prior to fixation
with 2% paraformaldehyde for 20 min at RT in the dark. Each sample was
then analyzed in an Accuri C6 (BD Biosciences) fluorescence cytometer.
Preparation of sheared pili. The sheared-pilus preparations were col-
lected according to the protocol of Craig et al. using the modification of
Blais et al. (34, 35). Briefly, gonococcal strains FA7474 (pilC1 pilC2
pilE), FA7480 (PilC1 pilC2 PilE), and FA7534 [pilC2
PilC1(D708A) PilE] were grown overnight on GCB agar plates prior to
resuspension in 1 ml of cold 50 mM CHES (2-cyclohexylaminoethanesul-
fonic acid [pH 9.6]). Each suspension was then vortexed for 2 min and
then immediately centrifuged at 16,000  g for 10 min at RT. The cell
pellets were kept on ice, solubilized in 1% sodium dodecyl sulfate (SDS),
and quantitated using a bicinchoninic acid (BCA) assay (Thermo Scien-
tific). Samples were balanced according to the amount of protein in the
cell pellet and run on 4 to 12% SDS-PAGE (Invitrogen) and transferred to
nitrocellulose. For quantitation of PilE in the sheared-pilus supernatant,
Western blots were probed using a rabbit polyclonal antibody (NC809;
1:1,000 dilution) made to the peptide epitope of PilE (KSAVTGYYLNH
GIWPADNGA) from FA1090 A23 or a 1:500 dilution of monoclonal an-
tibody 4B5 (PilC). Antibody binding was detected using either horserad-
ish peroxidase (HRP)-conjugated goat anti-rabbit IgG (dilution,
1:10,000; GE Healthcare) or 1:10,000 HRP-conjugated goat anti-mouse
IgG (Sigma) and Western Lightning Plus-ECL enhanced chemilumines-
cence substrate (PerkinElmer). The amounts of PilE, PilC, and porin in
the cell pellet were quantitated similarly, with the porin detected using a
1:500 dilution of monoclonal antibody H5 (against FA1090 PorB). The
results were visualized by using the FluorChem E imaging system (Pro-
teinSimple) and quantitated by using Image J software.
Scanning electron microscopy. Each gonococcal strain was grown
overnight on GCB agar plates prior to being resuspended in GCB medium
with supplement I at a concentration of 5  107 CFU/ml. Poly-L-lysine-
coated coverslips (Becton Dickenson) were placed in the bottom of a
12-well tissue culture-treated plate (Falcon), to which 2 ml of each sus-
pension was added. The gonococci were allowed to gently settle onto the
coverslips for 2 h in an incubator at 37°C with 5% CO2 prior to one wash
with filtered-sterilized phosphate-buffered saline (PBS). Thereafter, the
culture was gently fixed with fresh 2.5% glutaraldehyde (Sigma) in filter-
sterilized PBS for 24 h. After glutaraldehyde fixation, the coverslips were
Cheng et al.
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processed at the Microscopy Services Laboratory at the University of
North Carolina, Chapel Hill. Each coverslip was washed 3 times with
filter-sterilized PBS and stained with 1% osmium tetroxide in PBS for 15
min. Coverslips were then washed 3 times with filter-sterilized distilled
deionized water (dIH2O). To ensure optimal staining with osmium te-
troxide (Sigma), fresh, filter-sterilized 1% tannic acid (Sigma) in dIH2O
was used to stain the coverslips for 10 min, followed by 3 washes with
filter-sterilized dIH2O. The final stain was fresh, filter-sterilized 1% uranyl
acetate and was used to stabilize the pili during scanning electron micos-
copy processing. After a 15-min incubation with 1% uranyl acetate, 3
washes were done with filter-sterilized dIH2O. The coverslips were dehy-
drated in subsequent incubations in 30%, 50%, 75%, and 90% ethanol
and twice with freshly opened 100% ethanol for 10 min each. The cover-
slips were then dried in a critical point dryer (Samdri 795), mounted, and
sputter coated with gold-palladium for 100 s. Samples were visualized in a
Zeiss Supra 25 FESEM at magnifications of 1,000, 25,000, 75,000,
and 100,000.
rPilC1 binding to whole cells by ELISA. ME180 cells were grown
overnight to approximately 90% confluence, rinsed once in fresh me-
dium, and incubated at 37°C with 5% CO2 with dilutions of rPilC1 in
medium. After 30 min, unbound protein was washed 3 times from cells
with PBS before incubation for 30 min with PilC monoclonal antibody
4B5 (which recognizes the C-terminal conserved epitope) in PBS with 1%
bovine serum albumin (BSA) added. Unbound antibody was washed
away as before and detected with a 1:10,000 dilution of goat anti-mouse
IgG-horseradish peroxidase conjugate (Sigma). ELISA reactivity was vi-
sualized with the Pierce 1-Step Ultra TMB-ELISA (TMB is 3,3=,5,5=-te-
tramethylbenzidine) and stopped with 1 M phosphoric acid. Optical den-
sities at 450 nm were corrected for differences in monoclonal antibody
recognition of the different protein preparations.
RESULTS
Neisseria gonorrhoeae adhesin PilC contains a conserved calci-
um-binding motif. Published studies have identified a calcium-
binding domain in the Pseudomonas aeruginosa protein PilY1,
which shares a high degree of homology with the PilC protein
from N. gonorrhoeae (25). Sequence alignments indicate that N.
gonorrhoeae PilC1 also has a calcium-binding domain in its C-ter-
minal (CT) domain and that this binding motif is conserved in
more than 100 PilC homologs (see Table S1 in the supplemental
material), including those of neisserial species, Kingella kingae,
and other Betaproteobacteria (Fig. 1). On the basis of the crystal
structure of the CT of P. aeruginosa PilY1, Asp-851, Asn-853, Asp-
855, and Asp-859 were identified as being Ca-chelating residues
(25). Those residues are conserved in the CT of N. gonorrhoeae
PilC1 and correspond to Asp-708, Asp-710, Asp-712, and Asp-
716, respectively, in this protein (Fig. 1). Therefore, we hypothe-
sized that N. gonorrhoeae PilC1 function would be impacted by
calcium binding.
Purification, expression, and function of native FA1090 full-
length recombinant PilC1 (FL rPilC1) and the C-terminal do-
main of PilC1 (CT rPilC1). To identify the fragments of PilC1
proteins that could be expressed as soluble proteins in E. coli, we
tested a series of PilC1 constructs in several E. coli cell lines (data
not shown). We found that full-length PilC1 (FL rPilC1) (residues
1 to 1014) and the C-terminal domain (CT rPilC1) (residues 497
to 1014) could be expressed as soluble proteins in E. coli
BL21(DE3) Origami 2 cells. SDS-PAGE showed that the purity of
purified FL rPilC1 and CT rPilC1 was over 95% (Fig. 2A). The
expression level of CT rPilC1was considerably higher than that of
FL rPilC1. Similarly, the maximum soluble concentration for CT
rPilC1 was much higher (10 mg/ml) than that of FL rPilC1 (0.76
mg/ml). To examine the disulfide bond formation of FL rPilC1
and CT rPilC1, we ran samples of each protein under reducing
and nonreducing conditions in an SDS-PAGE (Fig. 2B) (data not
shown). As expected, the nonreduced samples ran more slowly
than their reduced counterparts, and rPilC1 mirrored the behav-
ior of native PilC1 from gonococcal total membranes, indicating
that we had produced proteins containing intramolecular disul-
fide bonds (Fig. 2B).
Previous studies showed that FL rPilC1, purified from N. gon-
orrhoeae, is capable of blocking the adherence of N. gonorrhoeae to
human cells by competing with pilus-associated native PilC1 (14).
Thus, we examined the impact of the recombinant proteins FL
rPilC1 and CT rPilC1 on the adherence of N. gonorrhoeae strain
FA1090 to the human cell line ME180. FL rPilC1 inhibited the
adherence in a dose-dependent manner with a 50% inhibitory
concentration (IC50) of approximately 10 nM (Fig. 2C); this is
similar to the concentrations observed with native gonococcus-
expressed PilC (12). Our results also showed that CT rPilC1 did
not affect the adherence of N. gonorrhoeae to ME180 cells (Fig.
2B), consistent with the observation that the N-terminal portion
of neisserial PilC was associated with adherence (11). In accor-
dance with a published report using natively purified protein (12),
we found that heat-inactivated FL rPilC1 was unable to inhibit
gonococcal binding (data not shown). Taken together, our results
suggest that the recombinant FL rPilC1 obtained in this study is
likely well folded and able to mimic in vivo-expressed PilC1.
Confirmation of the calcium-binding domain using C-ter-
minal domain proteins. As we were able to successfully produce
FL rPilC1 and CT rPilC proteins, we then sought to make re-
combinant PilC1 proteins with single substitutions of each as-
partic acid in the calcium-binding domain (Table 1). The re-
sulting D708A, D710A, and D716A proteins were purified to
95% purity (data not shown). Using the fluorescent calcium
analog terbium, we showed that CT rPilC1 bound calcium with
a dissociation constant (Kd) of 0.9  0.2 M, similar to those
reported for P. aeruginosa PilY1 and K. kingae PilC1 (25, 36, 37)
(Fig. 3A). Moreover, all three of the tested changes to the as-
partic acid residues of the putative calcium-binding domain
(D708A, D710A, and D716A) eliminated the ability of PilC1 to
bind calcium (Fig. 3A).
FIG 1 Partial sequence alignment of calcium-binding motifs in PilC/Y1 or-
thologues from T4P-containing species. The numbers correspond to positions
in mature PilC1 N. gonorrhoeae FA1090. Previously, the PilY1 protein from P.
aeruginosa had been shown to have a set of 3 aspartic acid residues in the C
terminus that together with a asparagine and a valine form a calcium-binding
domain (25). Here we show that this conserved calcium-binding domain is
found in N. gonorrhoeae and several other T4P-producing species. Underlined
and boldface residues correspond to those predicted to be important to the
calcium-binding domain. The predicted amino acid sequence in this region is
highly conserved, with only a few conservative replacements across all of the
available gonococcal (17 sequences) and meningococcal (80 sequences) PilC
sequences. Positions that are 100% conserved are indicated by an asterisk at the
bottom of the alignment.
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To rule out the possibility that those aspartic acid-to-alanine
substitutions significantly disrupted the native structure of PilC,
we examined the secondary structure of each protein by far-UV
circular dichroism (CD) spectroscopy. No significant change in
CD profiles was observed between PilC calcium-binding domain
mutants and wt PilC. This indicated that the mutations did not
significantly disrupt the structure of the protein (Fig. 3B).
We also investigated the thermostability of the proteins carry-
ing the calcium-binding domain alterations compared to that of
calcium-bound (and chelated) wt CT rPilC1. We found no signif-
icant difference in the melting temperature (Tm) between all
forms of CT rPilC1 (Fig. 3C). These results further confirm that
mutations to the PilC1 calcium-binding domain did not change
the proteins’ structure or stability. Thus, we have confirmed both
that PilC1 binds calcium and that the residues D708, D710, and
D716 are important to this binding.
Biological assays to determine the effect of a calcium-bind-
ing defect on the function of PilC1. To examine the role calcium
plays in the function of PilC1 in vivo, we engineered several deriv-
atives of N. gonorrhoeae strain FA1090 containing mutations al-
tering the residues shown above to abrogate calcium binding.
These strains contained silent alterations of the G-string encoding
the signal peptide to prevent phase variation of their pilC1 gene
and deletions of their pilC2 genes so that it could not phase vary to
an “on” phase (Table 1). Western blot analysis of whole-cell ly-
sates showed that FA7489 [PilC1(D708A)] had wt-level expres-
sion, while for unclear reasons, FA7490 [PilC1(D710A)] and
FA7491 [PilC1(D716A)] had reduced PilC1 expression (Fig. 3D).
While these strains had some normal antigenic variation in their
pilE loci, all of the individual isolates of a given mutation ex-
pressed similar levels of PilC1 (data not shown). As a result, only
the pilC1(D708A) calcium-binding mutant was examined further.
The actual strain used was FA7534, which not only has the
pilC1(D708A) mutation, but is also PilE matched to our phase-
locked wt surrogate, FA7480, which was used in the remaining
studies.
Calcium-binding domain mutation affects gonococcal adhe-
sion to cervical epithelial cells. Initial gonococcal adhesion to
cervical epithelial cells involves both PilC and PilE (14). To ob-
serve whether a mutation in the calcium-binding domain affects
the ability of the gonococcus to adhere to target cells, we used an
adherence assay similar to that used previously (12). The N. gon-
orrhoeae strain expressing PilC1(D708A) (FA7534) exhibited sig-
nificantly reduced adherence to human ME180 cells compared
with the strain expressing wt PilC1, FA7480, but more than the
strain lacking pili and PilC1, FA7474 (Fig. 4A). We conclude that
disruption of the ability of PilC1 to bind calcium partially disrupts
the ability of N. gonorrhoeae cells to bind to human ME180 cells.
D708A mutation reduces transformation frequency in N.
gonorrhoeae. Competence for DNA uptake is another important
pilus-dependent biological function (19, 38). To determine if the
mutation in the calcium-binding domain of PilC1 affected this
function, we examined transformation frequency. As expected,
the nonpiliated strain (pilC1 pilE) had undetectable levels of
transformation (frequency of less than 9  106 transformants/
CFU), while the piliated strain (PilC1) had a transformation
frequency of 3  103 transformants/CFU when exposed to 4
g/ml transforming DNA and 6  104 transformants/CFU
when exposed to 100 ng/ml transforming DNA (Fig. 4B). The
calcium-binding-deficient PilC1(D708A) strain had significantly
less competence at higher levels of DNA than the piliated (PilC1)
strain, but it had equivalent competence at lower levels of DNA
(Fig. 4B). Therefore, the loss of the calcium-binding domain in
PilC1 appears to have a subtle effect on PilC’s contribution to
DNA uptake.
D708A mutation does not impact PilC1 localization to pili in
N. gonorrhoeae. We next investigated the ability of the
PilC1(D708A) mutant to localize to the surface of N. gonorrhoeae
by flow cytometry. The monoclonal antibody 4B5 recognized all
surface-exposed PilC, while the monoclonal antibody 1D5 only
recognized PilC1 when it was expressed in the context of an intact
pilus. We attribute this behavior to an interaction between PilC1
FIG 2 Recombinant FA1090 PilC1 purified as a soluble protein from E. coli retains properties of native PilC1. (A) Coomassie-stained gel with 5 g of purified
FA1090 rPilC1 full-length (FL; residues 1 to 1014) and C-terminal (CT; residues 497 to 1014) domain as soluble proteins from E. coli Origami 2 estimated to be
95% pure. (B) Western blot showing that PilC1 is reduction modifiable when expressed in E. coli Origami 2, as it is in Neisseria gonorrhoeae. Lanes 1 and 3 were
loaded with 35 g of FA1090 total membranes (TM), while lanes 2 and 4 were loaded with 1 g of FL rPilC1 purified from E. coli. Lanes 1 and 2 were boiled in
the presence of the reducing agent 5% -mercaptoethanol (Me), while lanes 3 and 4 were boiled in the absence of reducing agent. Shown beside each gel are the
relative migration positions of protein molecular mass markers. (C) Purified full-length PilC1 protein inhibits the adherence of Neisseria gonorrhoeae gonococci
(GC) to human epithelial cells in a dose-dependent manner. ME180 cells were preincubated with increasing concentrations of PilC1 proteins for 30 min before
being washed and incubated with N. gonorrhoeae strain FA1090 in the cell adherence assay. The assay was performed in triplicate on 3 days. The error bars
represent the standard error of the normalized fraction of adherent N. gonorrhoeae.
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and the pilus exposing the otherwise hidden N-terminal 1D5
epitope. The nonpiliated N. gonorrhoeae strain FA7474 (PilC1
PilE) was used as a negative control, and the strains FA7480
(PilC1 PilE) and FA7461 (PilC1 PilE) were used as positive
controls. Our results show that the amount of PilC1(D708A) on
the bacterial surface was not significantly reduced relative to wt
PilC1 (Fig. 5A), suggesting that the D708A mutation to the calci-
um-binding domain of PilC1 did not significantly interfere with
localization of PilC1 on the bacterial surface. In addition, the
amount of PilC1 associated with pilin was not affected by its ability
to bind calcium, as demonstrated by the binding of antibody 1D5
to both the calcium-binding mutant FA7534(D708A) and the wt
(Fig. 5A).
The calcium-binding domain mutation does not signifi-
cantly affect the amount of shearable pili on the bacterial sur-
face. To ascertain whether the inability of PilC1 to bind calcium
might affect its ability to mediate pilus biogenesis, we looked at the
amount of pili present on the bacterial cell surface. We grew each
of the strains for 18 h prior to resuspending them in CHES buffer,
followed by vigorous vortexing and centrifugation. The samples
were balanced by a BCA protein assay of whole-cell lysate, and
samples representing similar numbers of bacteria were evaluated
by Western blot analysis. The blots were probed with the indicated
antibodies (Fig. 5B). To further normalize the amount of shear
preparation between strains, the amount of PilE in the shear prep-
aration is presented as a ratio to the amount of PorB signal from
matched samples. The amount of PilE in the PilC1(D708A) mu-
tant, FA7534, was not detectably different from that of the wt
PilC1 gonococcal strain, FA7480, based on statistical analysis of
densitometry data. This indicates that, although the ability of the
pili in the D708A mutant to adhere and mediate transformation at
high levels of DNA is significantly impaired, this does not appear
to be due to a lack of pili present on the surface of the bacterium.
Scanning electron microscopy of the calcium-binding
D708A mutant shows pili on the bacterial surface. To confirm
the results of the shear pilin preparations, we examined our strains
FIG 3 Mutations affecting the conserved aspartic acid residues in the C-terminal calcium-binding domain of PilC1 abrogate binding of the calcium analogue
terbium (Tb) without grossly altering secondary structure. (A) Different CT rPilC1 constructs were titrated with increasing concentrations of TbCl3. The solid
line is a computer fit of the data using the one-site binding model. Solid circles show the terbium fluorescence of a 3.4 M solution of native soluble CT rPilC1at
increasing concentrations of TbCl3. The open circles, closed inverted triangles, and open triangles indicate the fluorescence of similar protein solutions, each with
one of the conserved aspartic acids altered. RFU, relative fluorescence units. (B) Far-UV circular dichroism spectra of CT PilC1 proteins (wt and calcium-binding
mutant), recorded in the absence or presence of CaCl2. (C) The change of ellipticity at 216 nm due to the increase of temperature was recorded. The melting
temperature (Tm) indicates the temperature at which the protein lost half of its ellipticity at 216 nm. (D) Mutant PilC1 proteins were not equally expressed in
Neisseria gonorrhoeae. Shown are two Western blots of gonococcal whole-cell lysates probed for PilC and PorB, balanced by culture density. The isolates used are
representative of strains expressing PilC1 with the different calcium-binding mutations (D708A, D710A, and D716A). The samples were equally loaded, as
judged by the Ponceau S stain of the blot, and Western blot signal was quantitated using ImageJ, corrected for minor variations in loading based on PorB signal
and expressed relative to a strain expressing wt PilC1 (FA7480). Since only the level of D708A mutant was similar to that of the wt PilC1 protein, only the D708A
mutant was used in the remaining studies.
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using scanning electron microscopy. As can be seen in Fig. 5C,
FA1090-derived strains are much less piliated than MS11 (includ-
ing the parental strain FA1090a23 [data not shown]). This made it
very difficult to evaluate piliation by both the shear pilin prepara-
tion experiments and scanning electron microscopy, as there is
very little piliation in our positive control FA7480 (wt PilC1
PilE). However, we did see some pili in the PilC1(D708A) strain,
FA7534, similar to our positive control FA7480 strain and more
than our negative control, FA7474 (pilC1 pilE). The low levels
of piliation in the FA1090 derivatives make it difficult to distin-
guish between true T4P and artifacts, such as extended membrane
blebs. We can, however, say that any residual fiberlike structures
in FA7474 do not contain PilE, since it is deleted in this strain, as
demonstrated in Fig. 5B. We also considered the possibility that
the residual fiberlike structures were DNA but consider this un-
likely, since they persisted even after treatment with Benzonase
nuclease (Novogen) (data not shown).
To ensure that a defect in calcium binding did not have a
direct effect on PilC1’s ability to mediate adherence, we con-
firmed the adherence function of FL rPilC1(D708A) protein in
both the PilC1 binding ELISA and a gonococcal adherence in-
hibition assay. FL rPilC1(D708A) actually bound better to
ME180 cells than did the FL wild-type protein, as measured by
whole-cell ELISA (Fig. 6A). One of the disadvantages of this
approach to measuring PilC binding to epithelial cells is that it
is a measurement of total binding—productive binding and
nonspecific binding. Subtle differences in the quality of the two
protein preparations may explain the increased binding of the
protein associated with reduced bacterial adherence. When FL
rPilC1(D708A) was used to inhibit the adherence of bacteria to
epithelial cells, it showed similar inhibition to FL rPilC1-wt
(Fig. 6B), suggesting that the recombinant PilC1(D708A) used
in this study is likely well folded and able to compete with in
vivo-expressed PilC1 in adherence to epithelial cells. More im-
portantly, the mutation in the calcium-binding domain of
PilC1 does not interfere with the ability of FL rPilC1 to bind to
its receptor on ME180 cells and inhibit gonococcal binding.
DISCUSSION
N. gonorrhoeae is well established as a sexually transmitted human
pathogen and the cause of numerous inflammatory diseases, such
as pharyngitis, endocarditis, and pelvic inflammatory disease (39,
40). During infection, N. gonorrhoeae interacts with numerous
cells types, including epithelial cells. The initial adhesion events of
gonococcal infection are believed to involve gonococcal PilC and
PilE. PilE has been proposed to interact with CD147 on endothe-
lial cells during adherence of N. meningitidis (18), although much
remains to be elucidated about gonococcal adherence (12, 13, 16).
PilC was originally proposed as an adhesin located at the tip of the
pilus (13) and is also thought to act as an antagonist of the pilus
retraction protein PilT (9). The delicate balance between retrac-
tion and antagonist forces may allow PilC to initially interact with
its host-specific receptor, followed by the gonococcus being repo-
sitioned closer to the epithelial cell due to retraction.
Recently, another PilC family member, PilY1 in P. aeruginosa,
was found to have a calcium-binding domain that reduced the
amount of type IV pili found on the surface of the bacterium (25).
PilC from N. gonorrhoeae also has this conserved domain, which
has been found in other PilC family members as well (Fig. 1; see
Table S1 in the supplemental material) (37). The focus of this
study was to observe whether the calcium-binding domain in the
N. gonorrhoeae T4P adhesion protein, PilC, also affected piliation
in the same manner as that previously seen in P. aeruginosa.
First, we defined a new expression and purification method for
recombinant full-length and C-terminal PilC1 (Fig. 2A). We con-
firmed that the E. coli-expressed FL rPilC1 had a reduction mobil-
ity shift similar to that of the gonococcus-expressed PilC1 (Fig.
2B), indicating that it probably formed some of the same disulfide
bonds as the natively expressed protein when expressed in an E.
coli strain (Origami 2) containing the trxB and gor mutations to
enhance disulfide bond formation (41). More importantly, this FL
rPilC1 protein retained the ability to competitively inhibit gono-
coccal binding, similar to the previously published gonococcus-
expressed PilC protein (Fig. 2C) (12). This argues that the N-ter-
minal region, which is predicted to have a much less ordered
structure than the C-terminal region and has been implicated in
epithelial cell binding (11), retains a functionally relevant amount
of its native structure. The secondary structure of the C-terminal
region was sufficiently intact to bind calcium (Fig. 3A) and re-
mained unchanged even in the versions of the protein altered to
no longer bind calcium (Fig. 3B and C). Using these recombinant
proteins, we confirmed that the adhesion region of PilC1 was N-
terminal domain dependent and that purified FL PilC1 and
FIG 4 Gonococcal mutant expressing calcium-binding-deficient PilC1 is less
adherent to ME180 cells and less competent for DNA transformation under
some conditions. (A) The FA1090 derivative expressing the PilC1(D708A)
calcium-binding mutation was significantly less adherent than the wild type to
ME180 cells in a viable count adherence assay (P 	 0.01). Error bars indicate
the standard errors of the mean (SEM) of triplicate determinations from 6
days. Asterisks indicate a significant difference compared to the wild-type
PilC1-expressing strain. (B) Relative transformation frequency of strains
FA7474, FA7480, and FA7534 after receiving 100 ng/ml or 4000 ng/ml of
transforming DNA (normalized to FA7480). FA7534 was only significantly
different from FA7480 when exposed to 4000 ng/ml transforming DNA (de-
noted by * [P 	 0.05]). The error bars represent the SEM of 4 independent
determinations. Statistical significance was determined by one-way analysis of
variance (ANOVA) with Tukey’s posttest, and P values of 	0.05 were consid-
ered significant.
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PilC1(D708A), but not CT PilC1, proteins could be used as com-
petitive inhibitors of N. gonorrhoeae binding to ME180 cells (Fig.
2C and 6B). Having characterized the calcium-binding domain by
making changes at residues D708, D710, and D716 (Fig. 1 and
3A), we found that, while all of these residues are important for
binding calcium, only one, D708A, was expressed at wt levels in N.
gonorrhoeae (Fig. 3D). This mutant was used in the remainder of
this study. We are at present unsure of why there was unequal
expression of the different mutant PilC1 proteins. Perhaps this is
indicative of necessary interactions of other neisserial proteins
with PilC1 during trafficking of PilC1 to the surface of the bacte-
rium or otherwise affecting the in vivo stability of PilC1. Finally,
the method defined here to successfully express and purify both
recombinant full-length and C-terminal PilC1 could prove bene-
ficial in determining the specific PilC1 N-terminal domain resi-
dues responsible for adhesion in future studies.
While previous studies found that elimination of the ability of
PilY1 (the P. aeruginosa PilC homolog) to bind calcium abolished
both adhesion and twitching by preventing surface piliation in P.
aeruginosa (25, 36), the attenuated adhesion observed in K. kingae
(37) and this study for N. gonorrhoeae was not dependent on pre-
venting the surface expression of pili. We found that while the
FIG 5 A gonococcal mutant expressing calcium-binding-deficient PilC1 expresses pili that are indistinguishable from those of the wild type. (A) The surface
exposure of calcium-binding mutant PilC1(D708A) was similar to that of the wild type. Binding of two different monoclonal antibodies to whole bacteria was
measured by flow cytometry. Monoclonal antibody 4B5 bound to all surface-exposed PilC1, regardless of the expression of PilE, while monoclonal 1D5 only
bound to PilC1 when presented in the context of an intact pilus. (The negative control is FA7461.) The amount of PilC1(D708A) on the surface of FA7534 was
not statistically different from that of the wild type based on the binding of either of these monoclonal antibodies. Error bars represent the standard deviations
(SD) of 5 independent determinations. (B) Western blots of whole-cell lysates and pilin shear preparations showed that gonococcus strains expressing calcium-
binding-deficient PilC1 produced comparable amounts of pili to the wild type. FA7474, FA7480, and FA7534 are shown as probed with antibodies recognizing
PilC1, PilE, or PorB. The samples were balanced by total protein in cell pellets. Shown in the graph is the ratio of Western signal of PilE-probed shear preparation
to PorB-probed whole-cell lysate from bacteria grown on four different days. (C) Scanning electron microscopy of MS11 and FA1090-derived strains expressing
either wt PilC1, PilC1(D708A), or no PilC1. Each panel depicts a representative grouping of bacteria. MS11 is shown in the upper left panel, the nonpiliated
control FA7474 (PilC1 PilE) is shown in the lower left panel, the wild-type surrogate FA7480 (PilC1 PilE) is shown in the upper right panel, and the
calcium-binding mutant FA7534 (PilE) [PilC1(D708A)] is shown in the lower right panel. The scale bar in the lower left corner represents 1 m. Statistical
significance was determined by one-way ANOVA with Tukey’s posttest, and P values of 	0.05 were considered significant.
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gonococcal calcium-binding-deficient PilC1 mutant was reduced
in its ability to adhere to epithelial cells, this defect could not be
attributed to a lack of piliation. Scanning electron microscopy and
a sheared pilin preparation showed that there were normal levels
of pili present on the D708A gonococcal surface (Fig. 5B and C).
The defect in calcium binding could be affecting the localization
or presentation of PilC; however, flow cytometric staining of
PilC1 also indicated normal levels of PilC1 on the surface of the
D708A-expressing gonococcal strain (Fig. 5A). The calcium-
binding defect could have altered the ability of the pili to properly
present the N-terminal PilC adhesion domain, but PilC’s expo-
sure was not altered even when a monoclonal antibody recogniz-
ing an N-terminal epitope was used.
In addition to a defect in adherence capability, the
PilC(D708A) mutant was reduced in its transformability but only
at larger amounts of transforming DNA (Fig. 4B). One potential
reason for these partially altered phenotypes in the face of appar-
ently equal piliation is that our measure of piliation was insuffi-
cient to measure a small effect on the level of piliation. This expla-
nation is inconsistent with the magnitude of the biological defects
(40 to 50%), assuming a linear relationship between either of the
defects and the amount of pili produced. Also at odds with this
explanation is evidence shown by Long et al. that even low levels of
pilin expression allow for substantial DNA transformation com-
petence (42).
An alternative explanation is that the quality of the pili being
produced is changed in the PilC1(D708A)-producing strain. If the
PilC1(D708A)-expressing strain produced fewer pili but they
were longer than those produced by the wt parent, it might explain
the observed biological effects while still yielding a similar amount
of shearable PilE. Fewer, longer pili in the mutant might make
them more prone to breakage and lead to the observed reduction
in adherence. Fewer pili during transformation might lead to a
partial defect in frequency only when nearly all of the pili are
saturated with bound DNA, while the effect of fewer pili was neg-
ligible when the DNA was in limiting supply.
Another explanation might be that the altered PilC1 led to a
change in the bundle-forming behavior of the pili, although bun-
dle formation is normally associated with the posttranslational
modification state of pili. Bundle-forming behavior of pili is
known to affect both interbacterial interactions as well as bacterial
adherence in N. meningitidis (43). We did not measure the post-
translational modifications of PilE of the strains used in these
studies, but since they are closely related, they are presumed to be
similar. Since it was very difficult to detect pili by scanning elec-
tron microscopy in these strains, it is certainly possible that a
difference in the number of pili, their length, or their bundle-
forming behavior could easily have gone unnoticed. Future stud-
ies might include additional electron microscopy to observe the
exact piliation state of bacteria expressing PilC(D708A) as well as
where the protein is located on the bacterial surface. It may be
necessary to extend the genetics developed in FA1090 into one or
more other strains based on the limited amount of pili expressed
by the parental strain.
T4P are used for a variety of cellular processes, including mo-
tility, DNA uptake, and adhesion-mediated infection (19, 35).
Here, we elucidate the importance of calcium-binding domains in
the PilC family of proteins. Although the mechanism by which
these calcium-binding domains control adhesion and some pilin
function is unclear, we extend the calcium-bound and -unbound
model for the PilC family of proteins in the control of pilus func-
tion.
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